Hepatic steatosis in patients with chronic hepatitis C virus genotype 2 or 3 does not affect viral response in patients treated with peginterferon α-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) for 16 or 24 weeks

2009 ◽  
Vol 29 (2) ◽  
pp. 237-241 ◽  
Author(s):  
Maribel Rodriguez-Torres ◽  
Sugantha Govindarajan ◽  
Moises Diago ◽  
Thomas Morgan ◽  
Bhupinderjit Anand ◽  
...  
Hepatology ◽  
2008 ◽  
Vol 47 (6) ◽  
pp. 1837-1845 ◽  
Author(s):  
Martin Lagging ◽  
Nina Langeland ◽  
Court Pedersen ◽  
Martti Färkkilä ◽  
Mads Rauning Buhl ◽  
...  

2012 ◽  
Vol 19 (9) ◽  
pp. 623-634 ◽  
Author(s):  
S. Pianko ◽  
S. Zeuzem ◽  
W.-L. Chuang ◽  
G. R. Foster ◽  
S. K. Sarin ◽  
...  

2013 ◽  
Vol 48 (7) ◽  
pp. 839-847 ◽  
Author(s):  
Martin Lagging ◽  
Karolina Rembeck ◽  
Mads Rauning Buhl ◽  
Peer Christensen ◽  
Olav Dalgard ◽  
...  

2013 ◽  
Vol 85 (9) ◽  
pp. 1523-1533 ◽  
Author(s):  
Hiroshi Abe ◽  
Yuta Aida ◽  
Haruya Ishiguro ◽  
Kai Yoshizawa ◽  
Nobuyoshi Seki ◽  
...  

2010 ◽  
Vol 139 (4) ◽  
pp. 1267-1276.e4 ◽  
Author(s):  
David R. Nelson ◽  
Yves Benhamou ◽  
Wan–Long Chuang ◽  
Eric J. Lawitz ◽  
Maribel Rodriguez–Torres ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document